Figure 1.
Expression of MDR1 and ABCG2 in the liver cancer stem cell (LCSC) population of Huh7 and PLC/PRF/5 cells. (a) The gating of viable cells using forward scatter (FSC) and side scatter (SSC). (b) The percentage of MDR1+ and ABCG2+ expression in the bulk tumor population. (c1,d1) The percentage of LCSC markers EpCAM and CD133 in the bulk tumor population. The cells shown in (c1) and (d1) were divided into four quadrants (Q1, Q2, Q3 and Q4). (c2–c5,d2–d5) The expression of MDR1 and ABCG2 in the cells from Q1, Q2, Q3 and Q4 of (c1) and (d1) was determined. The Huh7 and PLC/PRF/5 cells were stained with IgG isotype-matched control antibodies of (e) EpCAM and CD133 and (f) MDR1 and ABCG2. Horizontal and vertical axes denote expression intensity. One representative experiment of three is shown.